gonadotrophin releasing hormone
gonadotrophin releasing hormone: 1 clinical trial tracked.
gonadotrophin releasing hormone evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about gonadotrophin releasing hormone, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Primary endpoint: Number of Participants Disease-free Until Completion of Treatment (2 Years From Start of ADT)
InterventionalRandomizedopen22 enrolledStarted 2019-10Completion 2025-1250 sites · United StatesNRG Oncology